𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Results of a double-blind placebo-controlled study using ciprofloxacin for prevention of travelers' diarrhea

✍ Scribed by C. M. A. Rademaker; I. M. Hoepelman; M. J. H. M. Wolfhagen; H. Beumer; M. Rozenberg-Arska; J. Verhoef

Publisher
Springer
Year
1989
Tongue
English
Weight
624 KB
Volume
8
Category
Article
ISSN
0934-9723

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

A double-blind, placebo controlled, mult
A double-blind, placebo controlled, multicentre study of tacrine for alzheimer's disease
✍ Philip C. Wood; Professor C. Mark Castleden πŸ“‚ Article πŸ“… 1994 πŸ› John Wiley and Sons 🌐 English βš– 527 KB

The present study was designed to determine whether oral tacrine (tetrahydroaminoacridine, THA) improves the symptoms of patients with mild to moderate Alzheimer's disease. The study was a multicentre, randomized doubleblind, placebo controlled, parallel group study with individual determination of

Norfloxacin prevents spontaneous bacteri
Norfloxacin prevents spontaneous bacterial peritonitis recurrence in cirrhosis: Results of a double-blind, placebo-controlled trial
✍ Dr. Pere GinΓ©s; Antoni Rimola; RamΓ³n Planas; Victor Vargas; Francesc Marco; Manu πŸ“‚ Article πŸ“… 1990 πŸ› John Wiley and Sons 🌐 English βš– 958 KB

Eighty cirrhotic patients who had recovered from an episode of spontaneous bacterial peritonitis were included in a multicenter, double-blind trial aimed at comparing long-term norfloxacin administration (400 mglday; 40 patients) vs. placebo (40 patients) in the prevention of spontaneous bacterial p

LJP 394 for the prevention of renal flar
LJP 394 for the prevention of renal flare in patients with systemic lupus erythematosus: Results from a randomized, double-blind, placebo-controlled study
✍ Donato AlarcΓ³n-Segovia; James A. Tumlin; Richard A. Furie; James D. McKay; Mario πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 188 KB πŸ‘ 2 views

## Abstract ## Objective To determine whether LJP 394 delays or prevents renal flare in patients with systemic lupus erythematosus (SLE) and a history of renal disease. ## Methods In a 76‐week, double‐blind, placebo‐controlled study, 230 SLE patients were randomized to receive 16 weekly doses of